anmelden
FTSE All-Share
5.479,78
PKT
-90,59
PKT
-1,63
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.11.17 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 10.11.17 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 10.11.17 | AstraZeneca Hold | S&P Capital IQ | |
| 10.11.17 | National Grid Sell | S&P Capital IQ | |
| 09.11.17 | AstraZeneca Neutral | UBS AG | |
| 09.11.17 | BP Outperform | Credit Suisse Group | |
| 09.11.17 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 09.11.17 | Rio Tinto buy | Société Générale Group S.A. (SG) | |
| 09.11.17 | BT Group Neutral | Goldman Sachs Group Inc. | |
| 09.11.17 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 09.11.17 | Barclays Sector Perform | RBC Capital Markets | |
| 08.11.17 | Imperial Brands buy | Deutsche Bank AG | |
| 08.11.17 | Imperial Brands overweight | Morgan Stanley | |
| 08.11.17 | AstraZeneca buy | Citigroup Corp. | |
| 08.11.17 | Imperial Brands Neutral | JP Morgan Chase & Co. | |
| 08.11.17 | Barclays buy | HSBC | |
| 08.11.17 | BT Group overweight | Barclays Capital | |
| 08.11.17 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 08.11.17 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 08.11.17 | Barclays Sell | Goldman Sachs Group Inc. | |
| 07.11.17 | Shell (ex Royal Dutch Shell) overweight | Morgan Stanley | |
| 07.11.17 | BP overweight | Morgan Stanley | |
| 07.11.17 | Diageo overweight | JP Morgan Chase & Co. | |
| 07.11.17 | Prudential Hold | Jefferies & Company Inc. | |
| 07.11.17 | BT Group Neutral | Credit Suisse Group | |
| 07.11.17 | Shell (ex Royal Dutch Shell) Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.11.17 | BP Neutral | Goldman Sachs Group Inc. | |
| 07.11.17 | Shell (ex Royal Dutch Shell) buy | HSBC | |
| 07.11.17 | Shell (ex Royal Dutch Shell) buy | HSBC | |
| 07.11.17 | BP buy | HSBC | |
| 06.11.17 | Barclays buy | UBS AG | |
| 06.11.17 | GSK Underweight | Morgan Stanley | |
| 06.11.17 | Barclays buy | Deutsche Bank AG | |
| 06.11.17 | Shell (ex Royal Dutch Shell) buy | Deutsche Bank AG | |
| 03.11.17 | HSBC Sector Perform | RBC Capital Markets | |
| 03.11.17 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 03.11.17 | Shell (ex Royal Dutch Shell) Hold | Société Générale Group S.A. (SG) | |
| 03.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 03.11.17 | BP overweight | JP Morgan Chase & Co. | |
| 03.11.17 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. |